<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Home News Effect of Adjuvant Chemotherapy on Survival in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy back to News

Effect of Adjuvant Chemotherapy on Survival in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Written by The ASCO Post on January 9, 2023

New research found that receiving adjuvant chemotherapy improved survival in patients with pancreatic adenocarcinoma who received curative-intent surgery.

Topics: Press Coverage

Related Stories

General

Contact Us

Find a Doctor

Find a Researcher

Make a Gift

Resident/Fellow Resources

Graduate Medical Education

Center for Surgical Innovation

Health Sciences Library

Alumni

CU Anschutz Campus Resources

School of Medicine

CU Department Websites

CU Anschutz Campus Directory

Parking and Maps

© 2023  The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.